title: Long-term outcomes and morbidity after I125 brachytherapy for localised prostate cancer: an early UK series.
authors.forename: G O
authors.initials: GO
authors.lastname: Hellawell
authors.forename: K
authors.initials: K
authors.lastname: Ho
authors.forename: M
authors.initials: M
authors.lastname: Halliwell
authors.forename: H
authors.initials: H
authors.lastname: Appleby
authors.forename: K
authors.initials: K
authors.lastname: Le Monnier
authors.forename: I
authors.initials: I
authors.lastname: Boiangiu
authors.forename: D R
authors.initials: DR
authors.lastname: Davies
authors.forename: G
authors.initials: G
authors.lastname: Fellows
authors.forename: E
authors.initials: E
authors.lastname: Whipp
authors.forename: S F
authors.initials: SF
authors.lastname: Brewster
mesh_terms: D000368:Aged; D001918:Brachytherapy / Q000009:adverse effects* / Q000379:methods; D018450:Disease Progression; D006801:Humans; D007457:Iodine Radioisotopes / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D009017:Morbidity; D009367:Neoplasm Staging; D018579:Patient Selection; D010502:Perineum; D011471:Prostatic Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D012189:Retrospective Studies; D012307:Risk Factors; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D007457:Iodine Radioisotopes